Is Synergy Rx Legit? What Our Registry Shows (2026)

Is Synergy Rx a real, safe GLP-1 telehealth company? Verified pricing history, refund policy, states served, and four named compounding pharmacies, sourced from RangeYourself’s dated registry. No public Trustpilot or BBB listing was found as of our check.

By RangeYourselfLast verified July 14, 2026

Yes, Synergy Rx is a real, operating GLP-1 telehealth company. RangeYourself has independently verified its pricing directly against its own site on July 14, 2026, and its refund/cancellation terms and states served are published on its own site. The evidence for that verdict is the dated verification below, not a claim we’re asking you to take on faith.

When we verified Synergy Rx

RangeYourself verified Synergy Rx’s price once, on July 14, 2026, directly against Synergy Rx’s own site. That is a single verification, not an ongoing trail, so treat it as a snapshot and confirm current pricing with Synergy Rx.

Pricing verification history

July 14, 2026: $199/mo

Refund and cancellation policy

Synergy Rx’s own stated policy: Cash-pay subscription; cancellation and refund terms per Synergy Rx’s policy, confirm at enrollment.

Price and terms on file

Price: $199/mo (advertised starting price)

Membership fee: No separate membership fee

Intro offer: $100 welcome credit at checkout; '2026 Promo Applied' banner active

Price last verified: July 14, 2026

States served

Synergy Rx ships to all 50 US states plus Washington, D.C., per its own site (verified July 14, 2026).

Verified programs that cost less than Synergy Rx

Synergy Rx’s own verified figure is $199/mo (advertised starting price). Every program below carries a lower all-in monthly price that we verified on the provider’s own pricing page, ranked lowest first as of November 10, 2026.

1.Embody
$69/mo (limited-time promo), verified October 21, 2026
See pricing →
2.Yucca Health
$69/mo (12-month plan rate), verified November 7, 2026
See pricing →
3.HealthRX
$97/mo (12-month Subscribe & Save plan rate), verified November 10, 2026
See pricing →
4.Sprout Health
$99/mo (12-month plan rate), verified November 3, 2026
See pricing →
5.Strut Health
$99/mo (sublingual/oral starting price), verified September 28, 2026
See pricing →

Prices are each provider’s own published all-in monthly figure at the plan term shown, verified on the date listed. RangeYourself may earn a commission from some programs; that can only break an exact tie between verified equals and never changes the price order.

Check Synergy Rx pricing → Read the full Synergy Rx review →

Frequently asked questions

Is Synergy Rx a real company?

Yes. RangeYourself has independently verified Synergy Rx's pricing directly against its own site (synergyrx.co) on July 14, 2026, a single dated verification on file, and its refund policy and states served are published on its own site.

Is Synergy Rx FDA-approved?

No. Synergy Rx prescribes compounded semaglutide and/or tirzepatide. Synergy Rx does not state whether its pharmacy is a 503A or 503B facility in the material we reviewed, so we have not confirmed the facility type. Compounded medication is not individually FDA-approved as a finished product. The shortage-era compounding pathway ended after the FDA declared the semaglutide shortage resolved on February 21, 2025 and the tirzepatide shortage resolved in December 2024, so compounding now proceeds under the ordinary rules for individual patients.

Does Synergy Rx offer refunds or a guarantee?

Synergy Rx's own stated policy: Cash-pay subscription; cancellation and refund terms per Synergy Rx’s policy, confirm at enrollment. This is the program's own policy, not a promise from RangeYourself, confirm current terms directly with Synergy Rx before enrolling.

What do independent reviews show for Synergy Rx?

We found no public Trustpilot or BBB listing for Synergy Rx as of our check on July 24, 2026. The absence of a listing is not evidence of a problem, but it also means there is no independent third-party record to cite.

Related guides

About compounded GLP-1 medicationsCompounded semaglutide and tirzepatide are not FDA-approved finished products. They are prepared by state-licensed 503A pharmacies or 503B outsourcing facilities and are not individually reviewed by the FDA for safety, effectiveness, or quality. Compounders describe these preparations as using the same active ingredient as the approved medicines; the FDA has warned that some compounded products use salt forms, semaglutide sodium or semaglutide acetate, that it considers different active ingredients from the approved drug, and has issued warning letters over marketing that presents a compounded preparation as interchangeable with an approved one. The FDA declared the semaglutide shortage resolved on February 21, 2025 and the tirzepatide shortage resolved in December 2024, so the shortage-era pathway for broad compounding of these drugs has ended. Compounding now proceeds under the ordinary rules: a 503A pharmacy compounding for an individual patient on a prescription, or a 503B outsourcing facility, which compounds in bulk under CGMP and FDA registration rather than per patient. Those rules generally do not cover a product that is “essentially a copy” of an approved drug unless a prescriber documents a change that makes a significant difference for an individual patient. Talk to a clinician about contraindications including personal or family history of medullary thyroid carcinoma or MEN 2. RangeYourself does not provide medical advice, does not guarantee a prescription, and does not guarantee weight-loss results.

RangeYourself is reader-supported. We may earn a commission when you click on certain links, at no extra cost to you. Editorial recommendations are made independently. This legitimacy check reflects registry data verified through July 14, 2026 and may change.